Investigation of the Effect of Travoprost Ophthalmic Solution of Lowering Intraocular Pressure in Patients With Normal Tension Glaucoma
Phase of Trial: Phase IV
Latest Information Update: 18 May 2016
Price : $35 *
At a glance
- Drugs Travoprost (Primary)
- Indications Glaucoma
- Focus Therapeutic Use
- Sponsors Alcon
- 09 Feb 2016 Primary endpoint has been met. (Mean Change From Baseline in IOP (9:00 AM) at Week 4, Week 8, and Week 12), according to results published in the Advances in Therapy.
- 09 Feb 2016 Results published in the Advances in Therapy
- 30 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.